pharma · Melanoma · Alcohol Use Disorder · ADIL
ADIAL PHARMACEUTICALS
ADIAL PHARMACEUTICALS, INC.
Alida Pharmaceuticals is a pharma organization headquartered in CHARLOTTESVILLE, VA, ES. It trades on NYSE under ticker ADIL. Primary therapeutic focus areas include Melanoma, Alcohol Use Disorder, Tooth Loss, Diabetes M
CHARLOTTESVILLE, VA, ES HQ
2021 Founded
16 Employees
Public company Type
ADIL · NYSE Ticker
Company details
- Status
- Public
- HQ
- CHARLOTTESVILLE, VA, ES
- Founded
- 2021
- Employees
- 16
- Programs
- 6
- Drugs
- 9
- Patents
- 1
AD04 (ondansetron)
Phase 3 · small molecule · Alcohol Use Disorder
AD04 (ondansetron) for Alcohol Use Disorder is a Phase 3 program (small_molecule) at ADIAL PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Internal code AD04-301
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- ADIAL PHARMACEUTICALS, INC.
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Alcohol Use Disorder
- Status
- completed
- Trials
- 1